nodes	percent_of_prediction	percent_of_DWPC	metapath
Gadoversetamide—Gastrointestinal pain—Mitoxantrone—sarcoma	0.00128	0.00128	CcSEcCtD
Gadoversetamide—Thrombocytopenia—Etoposide—sarcoma	0.00127	0.00127	CcSEcCtD
Gadoversetamide—Tachycardia—Etoposide—sarcoma	0.00127	0.00127	CcSEcCtD
Gadoversetamide—Abdominal pain—Vincristine—sarcoma	0.00127	0.00127	CcSEcCtD
Gadoversetamide—Body temperature increased—Vincristine—sarcoma	0.00127	0.00127	CcSEcCtD
Gadoversetamide—Skin disorder—Etoposide—sarcoma	0.00126	0.00126	CcSEcCtD
Gadoversetamide—Dry skin—Doxorubicin—sarcoma	0.00126	0.00126	CcSEcCtD
Gadoversetamide—Hyperhidrosis—Etoposide—sarcoma	0.00126	0.00126	CcSEcCtD
Gadoversetamide—Urticaria—Mitoxantrone—sarcoma	0.00124	0.00124	CcSEcCtD
Gadoversetamide—Anorexia—Etoposide—sarcoma	0.00124	0.00124	CcSEcCtD
Gadoversetamide—Diarrhoea—Thiotepa—sarcoma	0.00124	0.00124	CcSEcCtD
Gadoversetamide—Abdominal pain—Mitoxantrone—sarcoma	0.00123	0.00123	CcSEcCtD
Gadoversetamide—Body temperature increased—Mitoxantrone—sarcoma	0.00123	0.00123	CcSEcCtD
Gadoversetamide—Diarrhoea—Dactinomycin—sarcoma	0.00123	0.00123	CcSEcCtD
Gadoversetamide—Nasopharyngitis—Doxorubicin—sarcoma	0.00123	0.00123	CcSEcCtD
Gadoversetamide—Hypotension—Etoposide—sarcoma	0.00121	0.00121	CcSEcCtD
Gadoversetamide—Muscular weakness—Doxorubicin—sarcoma	0.00121	0.00121	CcSEcCtD
Gadoversetamide—Alanine aminotransferase increased—Doxorubicin—sarcoma	0.00121	0.00121	CcSEcCtD
Gadoversetamide—Dysuria—Epirubicin—sarcoma	0.0012	0.0012	CcSEcCtD
Gadoversetamide—Dizziness—Thiotepa—sarcoma	0.0012	0.0012	CcSEcCtD
Gadoversetamide—Dysphagia—Doxorubicin—sarcoma	0.00119	0.00119	CcSEcCtD
Gadoversetamide—Asthma—Doxorubicin—sarcoma	0.00119	0.00119	CcSEcCtD
Gadoversetamide—Influenza—Doxorubicin—sarcoma	0.00119	0.00119	CcSEcCtD
Gadoversetamide—Hypersensitivity—Vincristine—sarcoma	0.00118	0.00118	CcSEcCtD
Gadoversetamide—Paraesthesia—Etoposide—sarcoma	0.00117	0.00117	CcSEcCtD
Gadoversetamide—Dyspnoea—Etoposide—sarcoma	0.00116	0.00116	CcSEcCtD
Gadoversetamide—Hyperglycaemia—Epirubicin—sarcoma	0.00116	0.00116	CcSEcCtD
Gadoversetamide—Somnolence—Etoposide—sarcoma	0.00116	0.00116	CcSEcCtD
Gadoversetamide—Hypersensitivity—Mitoxantrone—sarcoma	0.00115	0.00115	CcSEcCtD
Gadoversetamide—Asthenia—Vincristine—sarcoma	0.00115	0.00115	CcSEcCtD
Gadoversetamide—Vomiting—Thiotepa—sarcoma	0.00115	0.00115	CcSEcCtD
Gadoversetamide—Pneumonia—Epirubicin—sarcoma	0.00115	0.00115	CcSEcCtD
Gadoversetamide—Vomiting—Dactinomycin—sarcoma	0.00114	0.00114	CcSEcCtD
Gadoversetamide—Rash—Thiotepa—sarcoma	0.00114	0.00114	CcSEcCtD
Gadoversetamide—Dermatitis—Thiotepa—sarcoma	0.00114	0.00114	CcSEcCtD
Gadoversetamide—Headache—Thiotepa—sarcoma	0.00113	0.00113	CcSEcCtD
Gadoversetamide—Rash—Dactinomycin—sarcoma	0.00113	0.00113	CcSEcCtD
Gadoversetamide—Decreased appetite—Etoposide—sarcoma	0.00113	0.00113	CcSEcCtD
Gadoversetamide—Gastrointestinal disorder—Etoposide—sarcoma	0.00112	0.00112	CcSEcCtD
Gadoversetamide—Asthenia—Mitoxantrone—sarcoma	0.00112	0.00112	CcSEcCtD
Gadoversetamide—Fatigue—Etoposide—sarcoma	0.00112	0.00112	CcSEcCtD
Gadoversetamide—Pain—Etoposide—sarcoma	0.00111	0.00111	CcSEcCtD
Gadoversetamide—Constipation—Etoposide—sarcoma	0.00111	0.00111	CcSEcCtD
Gadoversetamide—Urinary tract infection—Epirubicin—sarcoma	0.00111	0.00111	CcSEcCtD
Gadoversetamide—Conjunctivitis—Epirubicin—sarcoma	0.00111	0.00111	CcSEcCtD
Gadoversetamide—Dysuria—Doxorubicin—sarcoma	0.00111	0.00111	CcSEcCtD
Gadoversetamide—Diarrhoea—Vincristine—sarcoma	0.0011	0.0011	CcSEcCtD
Gadoversetamide—Haematuria—Epirubicin—sarcoma	0.00109	0.00109	CcSEcCtD
Gadoversetamide—Epistaxis—Epirubicin—sarcoma	0.00108	0.00108	CcSEcCtD
Gadoversetamide—Nausea—Thiotepa—sarcoma	0.00107	0.00107	CcSEcCtD
Gadoversetamide—Sinusitis—Epirubicin—sarcoma	0.00107	0.00107	CcSEcCtD
Gadoversetamide—Feeling abnormal—Etoposide—sarcoma	0.00107	0.00107	CcSEcCtD
Gadoversetamide—Hyperglycaemia—Doxorubicin—sarcoma	0.00107	0.00107	CcSEcCtD
Gadoversetamide—Diarrhoea—Mitoxantrone—sarcoma	0.00107	0.00107	CcSEcCtD
Gadoversetamide—Nausea—Dactinomycin—sarcoma	0.00107	0.00107	CcSEcCtD
Gadoversetamide—Pneumonia—Doxorubicin—sarcoma	0.00106	0.00106	CcSEcCtD
Gadoversetamide—Gastrointestinal pain—Etoposide—sarcoma	0.00106	0.00106	CcSEcCtD
Gadoversetamide—Dizziness—Vincristine—sarcoma	0.00106	0.00106	CcSEcCtD
Gadoversetamide—Urticaria—Etoposide—sarcoma	0.00103	0.00103	CcSEcCtD
Gadoversetamide—Haemoglobin—Epirubicin—sarcoma	0.00103	0.00103	CcSEcCtD
Gadoversetamide—Rhinitis—Epirubicin—sarcoma	0.00103	0.00103	CcSEcCtD
Gadoversetamide—Body temperature increased—Etoposide—sarcoma	0.00103	0.00103	CcSEcCtD
Gadoversetamide—Abdominal pain—Etoposide—sarcoma	0.00103	0.00103	CcSEcCtD
Gadoversetamide—Conjunctivitis—Doxorubicin—sarcoma	0.00103	0.00103	CcSEcCtD
Gadoversetamide—Urinary tract infection—Doxorubicin—sarcoma	0.00103	0.00103	CcSEcCtD
Gadoversetamide—Haemorrhage—Epirubicin—sarcoma	0.00103	0.00103	CcSEcCtD
Gadoversetamide—Hypoaesthesia—Epirubicin—sarcoma	0.00102	0.00102	CcSEcCtD
Gadoversetamide—Vomiting—Vincristine—sarcoma	0.00102	0.00102	CcSEcCtD
Gadoversetamide—Pharyngitis—Epirubicin—sarcoma	0.00102	0.00102	CcSEcCtD
Gadoversetamide—Urinary tract disorder—Epirubicin—sarcoma	0.00101	0.00101	CcSEcCtD
Gadoversetamide—Rash—Vincristine—sarcoma	0.00101	0.00101	CcSEcCtD
Gadoversetamide—Dermatitis—Vincristine—sarcoma	0.00101	0.00101	CcSEcCtD
Gadoversetamide—Oedema peripheral—Epirubicin—sarcoma	0.00101	0.00101	CcSEcCtD
Gadoversetamide—Haematuria—Doxorubicin—sarcoma	0.00101	0.00101	CcSEcCtD
Gadoversetamide—Urethral disorder—Epirubicin—sarcoma	0.00101	0.00101	CcSEcCtD
Gadoversetamide—Headache—Vincristine—sarcoma	0.001	0.001	CcSEcCtD
Gadoversetamide—Epistaxis—Doxorubicin—sarcoma	0.000997	0.000997	CcSEcCtD
Gadoversetamide—Vomiting—Mitoxantrone—sarcoma	0.000993	0.000993	CcSEcCtD
Gadoversetamide—Sinusitis—Doxorubicin—sarcoma	0.000991	0.000991	CcSEcCtD
Gadoversetamide—Rash—Mitoxantrone—sarcoma	0.000985	0.000985	CcSEcCtD
Gadoversetamide—Dermatitis—Mitoxantrone—sarcoma	0.000984	0.000984	CcSEcCtD
Gadoversetamide—Headache—Mitoxantrone—sarcoma	0.000979	0.000979	CcSEcCtD
Gadoversetamide—Erythema multiforme—Epirubicin—sarcoma	0.000969	0.000969	CcSEcCtD
Gadoversetamide—Eye disorder—Epirubicin—sarcoma	0.000958	0.000958	CcSEcCtD
Gadoversetamide—Hypersensitivity—Etoposide—sarcoma	0.000957	0.000957	CcSEcCtD
Gadoversetamide—Tinnitus—Epirubicin—sarcoma	0.000956	0.000956	CcSEcCtD
Gadoversetamide—Haemoglobin—Doxorubicin—sarcoma	0.000953	0.000953	CcSEcCtD
Gadoversetamide—Nausea—Vincristine—sarcoma	0.000953	0.000953	CcSEcCtD
Gadoversetamide—Cardiac disorder—Epirubicin—sarcoma	0.000952	0.000952	CcSEcCtD
Gadoversetamide—Flushing—Epirubicin—sarcoma	0.000952	0.000952	CcSEcCtD
Gadoversetamide—Rhinitis—Doxorubicin—sarcoma	0.000951	0.000951	CcSEcCtD
Gadoversetamide—Haemorrhage—Doxorubicin—sarcoma	0.000949	0.000949	CcSEcCtD
Gadoversetamide—Hypoaesthesia—Doxorubicin—sarcoma	0.000944	0.000944	CcSEcCtD
Gadoversetamide—Pharyngitis—Doxorubicin—sarcoma	0.000942	0.000942	CcSEcCtD
Gadoversetamide—Urinary tract disorder—Doxorubicin—sarcoma	0.000937	0.000937	CcSEcCtD
Gadoversetamide—Oedema peripheral—Doxorubicin—sarcoma	0.000935	0.000935	CcSEcCtD
Gadoversetamide—Asthenia—Etoposide—sarcoma	0.000932	0.000932	CcSEcCtD
Gadoversetamide—Angiopathy—Epirubicin—sarcoma	0.00093	0.00093	CcSEcCtD
Gadoversetamide—Urethral disorder—Doxorubicin—sarcoma	0.00093	0.00093	CcSEcCtD
Gadoversetamide—Nausea—Mitoxantrone—sarcoma	0.000928	0.000928	CcSEcCtD
Gadoversetamide—Immune system disorder—Epirubicin—sarcoma	0.000926	0.000926	CcSEcCtD
Gadoversetamide—Mediastinal disorder—Epirubicin—sarcoma	0.000924	0.000924	CcSEcCtD
Gadoversetamide—Chills—Epirubicin—sarcoma	0.00092	0.00092	CcSEcCtD
Gadoversetamide—Pruritus—Etoposide—sarcoma	0.000919	0.000919	CcSEcCtD
Gadoversetamide—Arrhythmia—Epirubicin—sarcoma	0.000916	0.000916	CcSEcCtD
Gadoversetamide—Mental disorder—Epirubicin—sarcoma	0.000898	0.000898	CcSEcCtD
Gadoversetamide—Erythema multiforme—Doxorubicin—sarcoma	0.000897	0.000897	CcSEcCtD
Gadoversetamide—Erythema—Epirubicin—sarcoma	0.000892	0.000892	CcSEcCtD
Gadoversetamide—Malnutrition—Epirubicin—sarcoma	0.000892	0.000892	CcSEcCtD
Gadoversetamide—Diarrhoea—Etoposide—sarcoma	0.000889	0.000889	CcSEcCtD
Gadoversetamide—Eye disorder—Doxorubicin—sarcoma	0.000887	0.000887	CcSEcCtD
Gadoversetamide—Tinnitus—Doxorubicin—sarcoma	0.000884	0.000884	CcSEcCtD
Gadoversetamide—Flushing—Doxorubicin—sarcoma	0.00088	0.00088	CcSEcCtD
Gadoversetamide—Cardiac disorder—Doxorubicin—sarcoma	0.00088	0.00088	CcSEcCtD
Gadoversetamide—Flatulence—Epirubicin—sarcoma	0.000879	0.000879	CcSEcCtD
Gadoversetamide—Tension—Epirubicin—sarcoma	0.000876	0.000876	CcSEcCtD
Gadoversetamide—Dysgeusia—Epirubicin—sarcoma	0.000874	0.000874	CcSEcCtD
Gadoversetamide—Nervousness—Epirubicin—sarcoma	0.000867	0.000867	CcSEcCtD
Gadoversetamide—Back pain—Epirubicin—sarcoma	0.000863	0.000863	CcSEcCtD
Gadoversetamide—Angiopathy—Doxorubicin—sarcoma	0.000861	0.000861	CcSEcCtD
Gadoversetamide—Dizziness—Etoposide—sarcoma	0.000859	0.000859	CcSEcCtD
Gadoversetamide—Muscle spasms—Epirubicin—sarcoma	0.000858	0.000858	CcSEcCtD
Gadoversetamide—Immune system disorder—Doxorubicin—sarcoma	0.000857	0.000857	CcSEcCtD
Gadoversetamide—Mediastinal disorder—Doxorubicin—sarcoma	0.000855	0.000855	CcSEcCtD
Gadoversetamide—Chills—Doxorubicin—sarcoma	0.000851	0.000851	CcSEcCtD
Gadoversetamide—Arrhythmia—Doxorubicin—sarcoma	0.000847	0.000847	CcSEcCtD
Gadoversetamide—Vision blurred—Epirubicin—sarcoma	0.000841	0.000841	CcSEcCtD
Gadoversetamide—Mental disorder—Doxorubicin—sarcoma	0.000831	0.000831	CcSEcCtD
Gadoversetamide—Ill-defined disorder—Epirubicin—sarcoma	0.000828	0.000828	CcSEcCtD
Gadoversetamide—Vomiting—Etoposide—sarcoma	0.000826	0.000826	CcSEcCtD
Gadoversetamide—Erythema—Doxorubicin—sarcoma	0.000826	0.000826	CcSEcCtD
Gadoversetamide—Malnutrition—Doxorubicin—sarcoma	0.000826	0.000826	CcSEcCtD
Gadoversetamide—Agitation—Epirubicin—sarcoma	0.00082	0.00082	CcSEcCtD
Gadoversetamide—Rash—Etoposide—sarcoma	0.000819	0.000819	CcSEcCtD
Gadoversetamide—Dermatitis—Etoposide—sarcoma	0.000819	0.000819	CcSEcCtD
Gadoversetamide—Headache—Etoposide—sarcoma	0.000814	0.000814	CcSEcCtD
Gadoversetamide—Flatulence—Doxorubicin—sarcoma	0.000814	0.000814	CcSEcCtD
Gadoversetamide—Tension—Doxorubicin—sarcoma	0.00081	0.00081	CcSEcCtD
Gadoversetamide—Dysgeusia—Doxorubicin—sarcoma	0.000809	0.000809	CcSEcCtD
Gadoversetamide—Malaise—Epirubicin—sarcoma	0.000805	0.000805	CcSEcCtD
Gadoversetamide—Nervousness—Doxorubicin—sarcoma	0.000802	0.000802	CcSEcCtD
Gadoversetamide—Vertigo—Epirubicin—sarcoma	0.000802	0.000802	CcSEcCtD
Gadoversetamide—Syncope—Epirubicin—sarcoma	0.0008	0.0008	CcSEcCtD
Gadoversetamide—Back pain—Doxorubicin—sarcoma	0.000799	0.000799	CcSEcCtD
Gadoversetamide—Muscle spasms—Doxorubicin—sarcoma	0.000794	0.000794	CcSEcCtD
Gadoversetamide—Palpitations—Epirubicin—sarcoma	0.000789	0.000789	CcSEcCtD
Gadoversetamide—Loss of consciousness—Epirubicin—sarcoma	0.000784	0.000784	CcSEcCtD
Gadoversetamide—Cough—Epirubicin—sarcoma	0.000779	0.000779	CcSEcCtD
Gadoversetamide—Vision blurred—Doxorubicin—sarcoma	0.000778	0.000778	CcSEcCtD
Gadoversetamide—Convulsion—Epirubicin—sarcoma	0.000773	0.000773	CcSEcCtD
Gadoversetamide—Nausea—Etoposide—sarcoma	0.000772	0.000772	CcSEcCtD
Gadoversetamide—Hypertension—Epirubicin—sarcoma	0.000771	0.000771	CcSEcCtD
Gadoversetamide—Ill-defined disorder—Doxorubicin—sarcoma	0.000766	0.000766	CcSEcCtD
Gadoversetamide—Chest pain—Epirubicin—sarcoma	0.00076	0.00076	CcSEcCtD
Gadoversetamide—Arthralgia—Epirubicin—sarcoma	0.00076	0.00076	CcSEcCtD
Gadoversetamide—Myalgia—Epirubicin—sarcoma	0.00076	0.00076	CcSEcCtD
Gadoversetamide—Agitation—Doxorubicin—sarcoma	0.000759	0.000759	CcSEcCtD
Gadoversetamide—Anxiety—Epirubicin—sarcoma	0.000757	0.000757	CcSEcCtD
Gadoversetamide—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—sarcoma	0.000755	0.000755	CcSEcCtD
Gadoversetamide—Discomfort—Epirubicin—sarcoma	0.000751	0.000751	CcSEcCtD
Gadoversetamide—Malaise—Doxorubicin—sarcoma	0.000745	0.000745	CcSEcCtD
Gadoversetamide—Dry mouth—Epirubicin—sarcoma	0.000743	0.000743	CcSEcCtD
Gadoversetamide—Vertigo—Doxorubicin—sarcoma	0.000742	0.000742	CcSEcCtD
Gadoversetamide—Syncope—Doxorubicin—sarcoma	0.000741	0.000741	CcSEcCtD
Gadoversetamide—Confusional state—Epirubicin—sarcoma	0.000734	0.000734	CcSEcCtD
Gadoversetamide—Palpitations—Doxorubicin—sarcoma	0.00073	0.00073	CcSEcCtD
Gadoversetamide—Oedema—Epirubicin—sarcoma	0.000728	0.000728	CcSEcCtD
Gadoversetamide—Anaphylactic shock—Epirubicin—sarcoma	0.000728	0.000728	CcSEcCtD
Gadoversetamide—Loss of consciousness—Doxorubicin—sarcoma	0.000726	0.000726	CcSEcCtD
Gadoversetamide—Cough—Doxorubicin—sarcoma	0.000721	0.000721	CcSEcCtD
Gadoversetamide—Shock—Epirubicin—sarcoma	0.000717	0.000717	CcSEcCtD
Gadoversetamide—Convulsion—Doxorubicin—sarcoma	0.000716	0.000716	CcSEcCtD
Gadoversetamide—Nervous system disorder—Epirubicin—sarcoma	0.000714	0.000714	CcSEcCtD
Gadoversetamide—Thrombocytopenia—Epirubicin—sarcoma	0.000713	0.000713	CcSEcCtD
Gadoversetamide—Hypertension—Doxorubicin—sarcoma	0.000713	0.000713	CcSEcCtD
Gadoversetamide—Tachycardia—Epirubicin—sarcoma	0.000711	0.000711	CcSEcCtD
Gadoversetamide—Skin disorder—Epirubicin—sarcoma	0.000708	0.000708	CcSEcCtD
Gadoversetamide—Hyperhidrosis—Epirubicin—sarcoma	0.000704	0.000704	CcSEcCtD
Gadoversetamide—Chest pain—Doxorubicin—sarcoma	0.000703	0.000703	CcSEcCtD
Gadoversetamide—Myalgia—Doxorubicin—sarcoma	0.000703	0.000703	CcSEcCtD
Gadoversetamide—Arthralgia—Doxorubicin—sarcoma	0.000703	0.000703	CcSEcCtD
Gadoversetamide—Anxiety—Doxorubicin—sarcoma	0.000701	0.000701	CcSEcCtD
Gadoversetamide—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—sarcoma	0.000698	0.000698	CcSEcCtD
Gadoversetamide—Discomfort—Doxorubicin—sarcoma	0.000695	0.000695	CcSEcCtD
Gadoversetamide—Anorexia—Epirubicin—sarcoma	0.000694	0.000694	CcSEcCtD
Gadoversetamide—Dry mouth—Doxorubicin—sarcoma	0.000688	0.000688	CcSEcCtD
Gadoversetamide—Hypotension—Epirubicin—sarcoma	0.000681	0.000681	CcSEcCtD
Gadoversetamide—Confusional state—Doxorubicin—sarcoma	0.00068	0.00068	CcSEcCtD
Gadoversetamide—Oedema—Doxorubicin—sarcoma	0.000674	0.000674	CcSEcCtD
Gadoversetamide—Anaphylactic shock—Doxorubicin—sarcoma	0.000674	0.000674	CcSEcCtD
Gadoversetamide—Musculoskeletal discomfort—Epirubicin—sarcoma	0.000664	0.000664	CcSEcCtD
Gadoversetamide—Shock—Doxorubicin—sarcoma	0.000663	0.000663	CcSEcCtD
Gadoversetamide—Nervous system disorder—Doxorubicin—sarcoma	0.000661	0.000661	CcSEcCtD
Gadoversetamide—Thrombocytopenia—Doxorubicin—sarcoma	0.00066	0.00066	CcSEcCtD
Gadoversetamide—Insomnia—Epirubicin—sarcoma	0.000659	0.000659	CcSEcCtD
Gadoversetamide—Tachycardia—Doxorubicin—sarcoma	0.000658	0.000658	CcSEcCtD
Gadoversetamide—Skin disorder—Doxorubicin—sarcoma	0.000655	0.000655	CcSEcCtD
Gadoversetamide—Paraesthesia—Epirubicin—sarcoma	0.000654	0.000654	CcSEcCtD
Gadoversetamide—Hyperhidrosis—Doxorubicin—sarcoma	0.000652	0.000652	CcSEcCtD
Gadoversetamide—Dyspnoea—Epirubicin—sarcoma	0.000649	0.000649	CcSEcCtD
Gadoversetamide—Somnolence—Epirubicin—sarcoma	0.000648	0.000648	CcSEcCtD
Gadoversetamide—Anorexia—Doxorubicin—sarcoma	0.000642	0.000642	CcSEcCtD
Gadoversetamide—Dyspepsia—Epirubicin—sarcoma	0.000641	0.000641	CcSEcCtD
Gadoversetamide—Decreased appetite—Epirubicin—sarcoma	0.000633	0.000633	CcSEcCtD
Gadoversetamide—Hypotension—Doxorubicin—sarcoma	0.00063	0.00063	CcSEcCtD
Gadoversetamide—Gastrointestinal disorder—Epirubicin—sarcoma	0.000629	0.000629	CcSEcCtD
Gadoversetamide—Fatigue—Epirubicin—sarcoma	0.000628	0.000628	CcSEcCtD
Gadoversetamide—Pain—Epirubicin—sarcoma	0.000623	0.000623	CcSEcCtD
Gadoversetamide—Constipation—Epirubicin—sarcoma	0.000623	0.000623	CcSEcCtD
Gadoversetamide—Musculoskeletal discomfort—Doxorubicin—sarcoma	0.000614	0.000614	CcSEcCtD
Gadoversetamide—Insomnia—Doxorubicin—sarcoma	0.00061	0.00061	CcSEcCtD
Gadoversetamide—Paraesthesia—Doxorubicin—sarcoma	0.000605	0.000605	CcSEcCtD
Gadoversetamide—Dyspnoea—Doxorubicin—sarcoma	0.000601	0.000601	CcSEcCtD
Gadoversetamide—Feeling abnormal—Epirubicin—sarcoma	0.0006	0.0006	CcSEcCtD
Gadoversetamide—Somnolence—Doxorubicin—sarcoma	0.000599	0.000599	CcSEcCtD
Gadoversetamide—Gastrointestinal pain—Epirubicin—sarcoma	0.000596	0.000596	CcSEcCtD
Gadoversetamide—Dyspepsia—Doxorubicin—sarcoma	0.000593	0.000593	CcSEcCtD
Gadoversetamide—Decreased appetite—Doxorubicin—sarcoma	0.000586	0.000586	CcSEcCtD
Gadoversetamide—Gastrointestinal disorder—Doxorubicin—sarcoma	0.000582	0.000582	CcSEcCtD
Gadoversetamide—Fatigue—Doxorubicin—sarcoma	0.000581	0.000581	CcSEcCtD
Gadoversetamide—Urticaria—Epirubicin—sarcoma	0.000579	0.000579	CcSEcCtD
Gadoversetamide—Pain—Doxorubicin—sarcoma	0.000576	0.000576	CcSEcCtD
Gadoversetamide—Constipation—Doxorubicin—sarcoma	0.000576	0.000576	CcSEcCtD
Gadoversetamide—Abdominal pain—Epirubicin—sarcoma	0.000576	0.000576	CcSEcCtD
Gadoversetamide—Body temperature increased—Epirubicin—sarcoma	0.000576	0.000576	CcSEcCtD
Gadoversetamide—Feeling abnormal—Doxorubicin—sarcoma	0.000555	0.000555	CcSEcCtD
Gadoversetamide—Gastrointestinal pain—Doxorubicin—sarcoma	0.000551	0.000551	CcSEcCtD
Gadoversetamide—Hypersensitivity—Epirubicin—sarcoma	0.000537	0.000537	CcSEcCtD
Gadoversetamide—Urticaria—Doxorubicin—sarcoma	0.000535	0.000535	CcSEcCtD
Gadoversetamide—Body temperature increased—Doxorubicin—sarcoma	0.000533	0.000533	CcSEcCtD
Gadoversetamide—Abdominal pain—Doxorubicin—sarcoma	0.000533	0.000533	CcSEcCtD
Gadoversetamide—Asthenia—Epirubicin—sarcoma	0.000523	0.000523	CcSEcCtD
Gadoversetamide—Pruritus—Epirubicin—sarcoma	0.000515	0.000515	CcSEcCtD
Gadoversetamide—Diarrhoea—Epirubicin—sarcoma	0.000498	0.000498	CcSEcCtD
Gadoversetamide—Hypersensitivity—Doxorubicin—sarcoma	0.000497	0.000497	CcSEcCtD
Gadoversetamide—Asthenia—Doxorubicin—sarcoma	0.000484	0.000484	CcSEcCtD
Gadoversetamide—Dizziness—Epirubicin—sarcoma	0.000482	0.000482	CcSEcCtD
Gadoversetamide—Pruritus—Doxorubicin—sarcoma	0.000477	0.000477	CcSEcCtD
Gadoversetamide—Vomiting—Epirubicin—sarcoma	0.000463	0.000463	CcSEcCtD
Gadoversetamide—Diarrhoea—Doxorubicin—sarcoma	0.000461	0.000461	CcSEcCtD
Gadoversetamide—Rash—Epirubicin—sarcoma	0.000459	0.000459	CcSEcCtD
Gadoversetamide—Dermatitis—Epirubicin—sarcoma	0.000459	0.000459	CcSEcCtD
Gadoversetamide—Headache—Epirubicin—sarcoma	0.000456	0.000456	CcSEcCtD
Gadoversetamide—Dizziness—Doxorubicin—sarcoma	0.000446	0.000446	CcSEcCtD
Gadoversetamide—Nausea—Epirubicin—sarcoma	0.000433	0.000433	CcSEcCtD
Gadoversetamide—Vomiting—Doxorubicin—sarcoma	0.000429	0.000429	CcSEcCtD
Gadoversetamide—Rash—Doxorubicin—sarcoma	0.000425	0.000425	CcSEcCtD
Gadoversetamide—Dermatitis—Doxorubicin—sarcoma	0.000425	0.000425	CcSEcCtD
Gadoversetamide—Headache—Doxorubicin—sarcoma	0.000422	0.000422	CcSEcCtD
Gadoversetamide—Nausea—Doxorubicin—sarcoma	0.0004	0.0004	CcSEcCtD
